Prevention of graft-versus-host-disease with preserved graft-versus-leukemia-effect by ex vivo and in vivo modulation of CD4+ T-cells

Allogeneic bone marrow grafts with high levels of CD4+CD25+FoxP3+ T cells can lead to engraftment failure

(2012) Stephan Fricke et al.   CYTOMETRY PART A

Boosting regulatory T cell function by CD4 stimulation enters the clinic

(2012) Christian Becker et al.   Frontiers in Immunology

Characterization of murine non-adherent bone marrow cells leading to recovery of endogenous hematopoiesis

(2010) Stephan Fricke et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis

(2010) G. HORNEFF et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Induction of high-dose tolerance to the rat anti-mouse IL-6 receptor antibody in NZB/NZW F1 mice

(2010) Hiroto Yoshida et al.   RHEUMATOLOGY INTERNATIONAL

Acute graft-versus-host disease: new treatment strategies

(2009) Sophie Paczesny et al.   CURRENT OPINION IN HEMATOLOGY

Differential control of allo-antigen-specific regulatory T cells and effector T cells by anti-CD4 and other agents in establishing transplantation tolerance

(2009) Kanji Nagahama et al.   INTERNATIONAL IMMUNOLOGY

Graft-versus-host disease

(2009) James LM Ferrara et al.   LANCET

Allogeneic Non-Adherent Bone Marrow Cells Facilitate Hematopoietic Recovery but Do Not Lead to Allogeneic Engraftment

(2009) Stephan Fricke et al.   PLoS One

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

(2008) M von Bonin et al.   BONE MARROW TRANSPLANTATION